FACTS ABOUT HEMGENIX REVEALED

Number of suitable sufferers: CDEC discussed the uncertainty in the quantity of people with reasonably serious to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some people who're categorized as getting mild or moderate disease may have a severe bleeding phenotype, which wou